B细胞非霍奇金淋巴瘤重要相关基因的研究进展
被引量:3
摘要
B细胞非霍奇金淋巴瘤(NHL)是常见肿瘤之一,其发生、发展、恶性程度及预后与基因的异常表达有密切关系。本文选择与B细胞NHL相关的基因,就其对B细胞增殖、分化、凋亡影响的研究进展做一综述。
出处
《国外医学(药学分册)》
2006年第3期174-177,共4页
Foreign Medical Sciences(Section of Pharmarcy)
参考文献20
-
1Hanahan D,Weinberg RA.The hallmarks of cancer[J].Cell,2000,100(1):57-70.
-
2Berglund M,Thunberd U,Amini RM,et al.Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis[J].Mod Pathol,2005,18(8):1113-1120.
-
3Biasoli I,Morais JC,Scheliga A,et al.CD10 and Bcl-2 expression combined with the International Prognostic Index can identify sub-groups of patients with diffuse large-cell lymphoma with very good or very poor prognoses[J].Histopathology,2005,46(3):328-333.
-
4Mahe B,Milpied N,Mellerin MP,et al.PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognoistic factor for event-free survival in patients with low-grade follicular non-Hodgkin′s lymphoma[J].Bone Marrow Transplant,2003,31(6):467-473.
-
5Oltersdorf T,Elmore SW,Shoemarker AR,et al.An inhibitor of Bcl-2 family proteins induces regression of solid tumours[J].Nature,2005,435(7042):677-681.
-
6Shin MS,Kim HS,Kang CS,et al.Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas[J].Blood,2002,99(11):4094-4099.
-
7Adida C,Haioun C,Gaulard P,et al.Prognostic significance of survivin expression in diffuse large B-cell lymphomas[J].Blood,2000,96(5):1921-1925.
-
8Ansell SM,Arendt BK,Grote DM,et al.Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin′s lymphoma[J].Leukemia,2004,18(3):616-623.
-
9Park CK,Oh YH.Expression of p63 in reactive hyperplasias and malignant lymphomas[J].J Korean Med Sci,2005,20(5):752-758.
-
10Hedvat CV,Teruya-Feldstein J,Puig P,et al.Expression of p63 in diffuse large B-cell lymphoma[J].Appl Immunohistochem Mol Mor-phol,2005,13(3):237-242.
同被引文献17
-
1罗春英,邓飞.非霍奇金淋巴瘤中p53基因突变情况研究[J].右江民族医学院学报,2006,28(5):712-714. 被引量:3
-
2蒋会勇,李慧灵,胡海,何滢,赵彤.弥漫性大B细胞淋巴瘤t(14;18)易位及bcl-2基因扩增的检测[J].中华病理学杂志,2007,36(2):84-89. 被引量:28
-
3陈天明.现代病理诊断规范与操作技术[M].2版.北京:中国科学文化出版社,2005:304-325.
-
4Lueas PC, Yonezumi M, Inohara N, et al. Be110 and MALT1 , independment targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-KB signaling pathway[J].J Bio Chem, 2001 (22):19012 - 19019.
-
5Sweredlow SH, Campo E,Harris NL, et al. Who classification of turnouts of haematopoietic and lymphoid tissues [ M]. IARC Press, 4th Edition, 2008:214 - 217, 233 - 237.
-
6Che T, You Y, Wang D, et al. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappa B activation[ J]. J Biol Chem,2004(16) : 1587 - 1586.
-
7Shambharkar PB, Blonska M, Pappu BP, et al. Phosphorylation and ubiquitination of the lkappa B kinase complex by two distinct signaling pathways [ J]. EMBO J, 2007(7) : 1794 - 1805.
-
8Zhou H, Wertz I, O' Rourke K, et al. BcllO activates the NF-Kappa B pathway through ubiquitination [ J ]. Nature, 2004(6970) : 167 - 171.
-
9赵宝玉,边大鹏,汪欣,汤坚强,万远廉,刘玉村,吴涛,潘义生,王鹏远.原发性胃肠道淋巴瘤的诊断与治疗[J].中国肿瘤临床与康复,2007,14(5):446-449. 被引量:14
-
10景红梅,克晓燕,董菲.49例MALT淋巴瘤临床资料分析[J].中国实验血液学杂志,2007,15(6):1293-1296. 被引量:8
引证文献3
-
1冯莉娟,张国平,谢岷,曹鹏飞,傅春燕,胡忠良,戴茂.原发性肠淋巴瘤p53基因与13q14染色体变异与预后的关系[J].中国当代儿科杂志,2009,11(7):555-558. 被引量:1
-
2王松,杨文秀,刘启兰,郭宏伟,裴媛媛.MALT1及Bcl2在MALT和DLBCL中的表达及意义[J].贵阳医学院学报,2009,34(6):625-628. 被引量:2
-
3冯莉娟,张桂英,张国平,胡忠良,曹鹏飞.原发性胃肠淋巴瘤p53基因与13q14染色体缺失与预后的关系[J].中华消化杂志,2010,30(3):149-153. 被引量:3
二级引证文献6
-
1岑岭,姜玉,陈涛,晁红颖,卢绪章.28例伴骨髓侵犯非霍奇金淋巴瘤的细胞遗传学分析[J].中华医学遗传学杂志,2019,36(5):429-432. 被引量:7
-
2杨文秀,陈玉梅,王松,孟青.弥漫大B细胞淋巴瘤中NFκB活化相关基因表达与Bcl2表达的关系[J].贵州医药,2010,34(11):963-967. 被引量:1
-
3陈宝伶,李树明.急性白血病患者骨髓组织血管新生与Bcl-2蛋白关系的研究[J].中国现代医药杂志,2011,13(11):35-38. 被引量:2
-
4孙冠星,曹祥山,李青,王志林.BCL-6、MYC和p53基因异常与弥漫性大B细胞淋巴瘤免疫学亚型及预后的关系[J].中华医学遗传学杂志,2012,29(5):576-581. 被引量:8
-
5何兰兰,严峰,刘德亮,曹祥山,谢晓宝,王志林.bcl-6、p53、c-myc基因异常在弥漫大B细胞淋巴瘤中的临床意义[J].白血病.淋巴瘤,2013,22(11):661-664. 被引量:4
-
6林静,周英琼.脱落细胞学的细胞块制作及应用的研究进展[J].医学综述,2014,20(15):2739-2740. 被引量:7
-
1王剑鹏,杨淑莲,王莉.慢性粒细胞白血病并发B细胞非霍奇金淋巴瘤1例报告[J].中国实用医药,2007,2(32).
-
2吕军,尹培达,沈清瑞.霉酚酸酯在肾移植及肾小球疾病中的应用[J].国外医学(内科学分册),1999,26(9):374-376.
-
3陈阳,曹平安,曹佃丽,马莉,李胜范.阿司匹林防治大肠癌的最新进展[J].中华临床医师杂志(电子版),2013,7(21):136-137. 被引量:7
-
4赵英智,郝凯峰,郑光辉.紫杉醇联合表阿霉素治疗晚期乳腺癌34例分析[J].中国实用医药,2007,2(29).
-
5勇威本.利妥昔单抗治疗B细胞淋巴瘤现状[J].世界临床药物,2007,28(5):274-277. 被引量:7
-
6钟亚华,谢丛华,周云峰.抗CD20单克隆抗体美罗华治疗B细胞淋巴瘤的研究进展[J].国外医学(输血及血液学分册),2002,25(1):60-63. 被引量:7
-
7抗癌药物研发进展[J].中国新药杂志,2011,20(4):294-294.
-
8杨敏,陈琦.耐药蛋白P-gp与Topo-Ⅱ在B细胞非霍奇金淋巴瘤中的表达及意义[J].中国药房,2012,23(18):1684-1687. 被引量:1
-
9金焱(摘).GSK得到了抗体OP—R003的权利[J].国外药讯,2008(6):35-36.
-
10谭鹤长.美罗华联合化疗治疗B细胞非霍奇金淋巴瘤的效果[J].柳州医学,2009,22(1):49-49. 被引量:1